UNITED STATES, June 24, 2019 (Web MD)- Cannabidiol, or CBD, already being researched and used for anxiety, insomnia, epilepsy and pain, may be the next superbug fighter for resistant infections, a new study suggests.The researchers tested CBD against a wide variety of bacteria, ''including bacteria that have become resistant to the most commonly...
U.S, January 13, 2020 (GREENENTREPRENEUR) It really depends on your tolerance and what conditions you are treating, but here we remove some of the dosing mystery.
The brave new world of cannabidiol or CBD-infused products is growing. That means more product choices and...
The potential of therapeutic cannabis is real. Since 1995, there have been over 25,000 peer-reviewed articles in various medical journals in the U.S. and around the world about the plant’s medicinal characteristics and potential for therapeutic use. Also during that time, over 30 states have approved medical cannabis programs...
UNITED KINGDOM, October 9, 2019, (HEALTH EUROPA) - Zelda Therapeutics Limited has announced a proposed merger of equals with Ilera Therapeutics LLC (Ilera Therapeutics).
Ilera Therapeutics is a privately held medical cannabis and cannabinoid science company based in the United States and, subject to approval from Zelda shareholders and all conditions of sale being met,...
Updates in science and the explosive growth of LEDs.
The last five years brought incredible developments to the world of cannabis lighting. From advances in light recipes, the infectious rise of Light-emitting diode lights (LEDs) across the industry, and to the upsetting of the long-heralded...
U.S, MARIJUANA BUSINESS DAILY (20 June 21) Recreational marijuana makes the most headlines, but a large number of cannabis consumers buy and use the plant for medical and wellness reasons.
These include acute medical conditions such as cancer, chronic pain and epilepsy, as well...